VIRTUE QA
ProNova Solutions · Decision date Sep 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for VIRTUE QA, a ProNova Solutions software-only device, on September 23, 2026, under 510(k) K260597. The submission falls under 21 CFR 892.5050 (Medical Charged-Particle Radiation Therapy System), Class II, product code LHN, in the radiology specialty. The public database lists the date received as February 24, 2026, while the clearance letter cites a dated August 17, 2026 and received August 18, 2026; the source does not reconcile the discrepancy.
The 510(k) summary describes four analysis modules plus offline image review, and names myQA iON (K201798) as predicate with Mobius3D (K153014) as reference device supporting CBCT-to-planning-CT registration. The comparison table labels pre-treatment predictive QA as a new capability and offline image review as supported by the reference device. The database page notes a Predetermined Change Control Plan authorized, and the summary contents list modifications for daily model retraining and additional proton vendor platforms; the supplied excerpts do not give their authorized scope.
The indications state the device is not a treatment planning system and does not control treatment delivery. No clinical performance data, patient-selection criteria, or independent efficacy findings appear in the supplied excerpts, so those remain unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260597
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ProNova Solutions
- Product code
- LHN
- Decision code
- SESE
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Radiation Therapy, Charged-Particle, Medical.
- Applicant
- ProNova Solutions
- Product code
- LHN
- FDA device class
- 2
FDA decision timeline
K260597 received
Application receipt date recorded by FDA.
K260597 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ProNova Solutions
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Maryville, TN
Sources and methodology
- Original FDA record: K260597
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records